Successful treatment of a large-sized triple-negative breast cancer: A case report.
Dong Zeng, Xiaolan Liu, Shenya Fu et al.
✦ AI-curated · Sources linked
Case in brief
A 38-year-old female with stage IV triple-negative breast cancer (TNBC) experienced tumor recurrence and rapid progression one year post-surgery. After consulting multiple hospitals, she received stereotactic body radiotherapy (SBRT) combined with chemotherapy, utilizing an ultrahigh-dose radiotherapy approach. The treatment resulted in significant tumor shrinkage with minimal side effects, and the tumor remained well controlled nine months later.
What made this case unusual
The use of an ultrahigh-dose radiotherapy modality during SBRT is rarely reported in the treatment of TNBC, making this case noteworthy.
Diagnostic / clinical pearl
Clinicians should consider innovative radiotherapy approaches, such as ultrahigh-dose SBRT, in managing aggressive cases of triple-negative breast cancer.
Why it matters
This case highlights the potential for novel treatment strategies in challenging cancer cases, which may improve patient outcomes in similar scenarios.